GGTA1 KO thymokidney

· United Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GGTA1 KO thymokidney, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD [Phase 1, Phase 2]